ABOS
Price
$1.12
Change
-$0.09 (-7.44%)
Updated
Jun 27 closing price
Capitalization
69.36M
50 days until earnings call
HRTX
Price
$2.14
Change
-$0.02 (-0.93%)
Updated
Jun 27 closing price
Capitalization
326.49M
44 days until earnings call
Interact to see
Advertisement

ABOS vs HRTX

Header iconABOS vs HRTX Comparison
Open Charts ABOS vs HRTXBanner chart's image
Acumen Pharmaceuticals
Price$1.12
Change-$0.09 (-7.44%)
Volume$5.68M
Capitalization69.36M
Heron Therapeutics
Price$2.14
Change-$0.02 (-0.93%)
Volume$5.48M
Capitalization326.49M
ABOS vs HRTX Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. HRTX commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and HRTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ABOS: $1.12 vs. HRTX: $2.14)
Brand notoriety: ABOS and HRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 1624% vs. HRTX: 326%
Market capitalization -- ABOS: $69.36M vs. HRTX: $326.49M
ABOS [@Biotechnology] is valued at $69.36M. HRTX’s [@Biotechnology] market capitalization is $326.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, HRTX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while HRTX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • HRTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -6.67% price change this week, while HRTX (@Biotechnology) price change was +7.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

HRTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($326M) has a higher market cap than ABOS($69.4M). HRTX YTD gains are higher at: 39.869 vs. ABOS (-34.884). HRTX has higher annual earnings (EBITDA): 2.76M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. HRTX (50.7M). ABOS has less debt than HRTX: ABOS (29M) vs HRTX (177M). HRTX has higher revenues than ABOS: HRTX (149M) vs ABOS (0).
ABOSHRTXABOS / HRTX
Capitalization69.4M326M21%
EBITDA-111.98M2.76M-4,060%
Gain YTD-34.88439.869-87%
P/E RatioN/AN/A-
Revenue0149M-
Total Cash149M50.7M294%
Total Debt29M177M16%
FUNDAMENTALS RATINGS
HRTX: Fundamental Ratings
HRTX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSHRTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGFEF3.27N/A
N/A
EUROBANK ERGASIAS SVCS AND HOLDINGS SA
HUBV0.11N/A
N/A
Hubb Ventures Inc.
JNPKF22.25N/A
N/A
Jenoptik AG
HONT117.35N/A
N/A
Honat Bancorp, Inc.
DSNKY22.88-0.08
-0.35%
Daiichi Sankyo Co., Ltd.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-7.44%
FHTX - ABOS
54%
Loosely correlated
-0.41%
CRBU - ABOS
53%
Loosely correlated
-5.19%
BEAM - ABOS
50%
Loosely correlated
-1.98%
IPSC - ABOS
49%
Loosely correlated
-5.74%
CRSP - ABOS
49%
Loosely correlated
N/A
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with ABOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.93%
ABOS - HRTX
39%
Loosely correlated
-7.44%
ACAD - HRTX
39%
Loosely correlated
-0.41%
ARDX - HRTX
38%
Loosely correlated
+0.14%
ABSI - HRTX
37%
Loosely correlated
-3.32%
RNAC - HRTX
36%
Loosely correlated
-6.81%
More